Functional analysis and intracellular localization of p53 modified by SUMO-1

被引:113
作者
Kwek, SSS [1 ]
Derry, J [1 ]
Tyner, AL [1 ]
Shen, ZY [1 ]
Gudkov, AV [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA
关键词
SUMO-1; p53; transactivation; cellular localization;
D O I
10.1038/sj.onc.1204362
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 tumor suppressor is a subject of several posttranslational modifications, including phosphorylation, ubiquitination and acetylation, which regulate p53 function. A new covalent modification of p53 at lysine 386 by SUMO-1 was recently identified. To elucidate the function of sumoylated p53, we compared the properties of wild type p53 and sumoylation-deficient p53 mutant, K386R, No differences were found between wild type p53 and K386R mutant of p53 in transactivation or growth suppression assays. Moreover, overexpression of SUMO-1 has no effect on p53-regulated transcription. Biochemical fractionation showed that sumoylated p53 is localized in the nucleus and is tightly bound to chromatin structures. p53 and SUMO-1 colocalized in PML nuclear bodies in 293 cells and the nucleoli in MCF7 and HT1080 cells. However, sumoylation-deficient p53 mutant showed a similar pattern of intranuclear localization, suggesting that SUMO-1 does not target p53 to subnuclear structures. These data indicate that SUMO-1 modification of p53 at lysine 386 may not be essential for p53's cellular localization, transcriptional activation, or growth regulation.
引用
收藏
页码:2587 / 2599
页数:13
相关论文
共 69 条
[1]  
Ashcroft M, 1999, MOL CELL BIOL, V19, P1751
[2]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[3]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[4]   DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation [J].
Blattner, C ;
Tobiasch, E ;
Litfen, M ;
Rahmsdorf, HJ ;
Herrlich, P .
ONCOGENE, 1999, 18 (09) :1723-1732
[5]  
Boddy MN, 1996, ONCOGENE, V13, P971
[6]   RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article) [J].
Buschmann, T ;
Fuchs, SY ;
Lee, CG ;
Pan, ZQ ;
Ronai, Z .
CELL, 2000, 101 (07) :753-762
[7]  
CARTER T, 1987, CANCER RES, V47, P803
[8]  
Chehab NH, 2000, GENE DEV, V14, P278
[9]   WILD-TYPE P53 MEDIATES APOPTOSIS BY E1A, WHICH IS INHIBITED BY E1B [J].
DEBBAS, M ;
WHITE, E .
GENES & DEVELOPMENT, 1993, 7 (04) :546-554
[10]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239